Publications by authors named "P Chaveeva"
: To evaluate the diagnostic accuracy of widely available biomarkers longitudinally measured throughout pregnancy to predict all and term (delivery at ≥37 weeks) preeclampsia (PE). : This is a longitudinal retrospective study performed at Hospital Universitario de Torrejón (Madrid, Spain) and Shterev Hospital (Sofia, Bulgaria) between August 2017 and December 2022. All pregnant women with singleton pregnancies and non-malformed live fetuses attending their routine ultrasound examination and first-trimester screening for preterm PE at 11 + 0 to 13 + 6 weeks' gestation at the participating centers were invited to participate in a larger study for the prediction of pregnancy complications.
View Article and Find Full Text PDFArticle Synopsis
- Marginal cord insertion (MCI) is considered a pathological condition that requires early diagnosis and understanding its risk factors can improve prenatal care.
- A meta-analysis of 18 studies revealed that the prevalence of MCI in singleton pregnancies is 5.71%, identifying significant risk factors such as assisted reproductive technology, chronic hypertension, placenta previa, and nulliparity.
- The analysis followed strict guidelines and methods to ensure quality, indicating that factors like smoking, maternal age, and prior Cesarean sections were not significantly associated with MCI.
Article Synopsis
- This meta-analysis investigates the risk factors associated with velamentous cord insertion (VCI), aiming to improve prenatal identification of the condition.
- It included data from 14 cohort and 4 case-control studies, encompassing over 952,000 singleton pregnancies, revealing an overall VCI prevalence of 1.54%.
- Key risk factors identified include assisted reproductive technology, being a first-time mother (nulliparity), smoking, and having placenta previa, which could help refine screening strategies for women at greater risk.
Management of preterm labor: Clinical practice guideline and recommendation by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation.
Eur J Obstet Gynecol Reprod Biol
December 2023
This practice guideline follows the mission of the World Association of Perinatal Medicine in collaboration with the Perinatal Medicine Foundation, bringing together groups and individuals throughout the world, with the goal of improving the management of preterm labor. In fact, this document provides further guidance for healthcare practitioners on the appropriate use of examinations with the aim to improve the accuracy in diagnosing preterm labor and allow timely and appropriate administration of tocolytics, antenatal corticosteroids and magnesium sulphate and avoid unnecessary or excessive interventions. Therefore, it is not intended to establish a legal standard of care.
View Article and Find Full Text PDF